EMA Authorised: Gliolan (5-aminolevulinic acid hydrochloride) — Photonamic GmbH & Co. KG

View source ↗

Summary

The EMA authorised Gliolan (5-aminolevulinic acid hydrochloride) for use in glioma, with Photonamic GmbH & Co. KG as the marketing authorization holder as of 30…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Gliolan (5-aminolevulinic acid)

Snippet

Status: Authorised. Therapeutic area: Glioma. MAH: Photonamic GmbH & Co. KG. Decision date: 30/10/2024